Connect with us

Hi, what are you looking for?

Thursday, Oct 6, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

Stock News

MindMed re-establishes Nasdaq listing requirements

News follows a 1-for-15 reverse share split by the company at the end of August and ensuing loss of stock value

MindMed satisfies Nasdaq listing requirements
Photo via MindMed.

Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) has now fulfilled the necessary requirements for continued listing on the Nasdaq stock exchange.

The news follows a 1-for-15 reverse share split of the company’s stock in August and a subsequent drop in MindMed’s share price afterward.

On Wednesday, MindMed announced that it had received a letter from Nasdaq Stock Market LLC informing the company that it had successfully regained compliance with the minimum bid price requisite of US$1.00 per share. Nasdaq has advised the company that the matter is now concluded.

Read more: MindMed announces initial patient dosing in MM-120 study

Read more: MindMed stock surges on Nasdaq listing approval

MindMed says its completion of the reverse share split and ensuing fulfillment of compliance regulations required by Nasdaq will enable the company to potentially accomplish multiple key corporate objectives.

These include the ability to satisfy particular “security eligibility criteria” to be considered for and included in the index of market-wide and healthcare sectors, increased liquidity of common shares with a broadened shareholder base and the potential to improve the company’s presence and overall visibility for investors.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

 

 

 

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Psychedelics

The company plans to use mushroom tea to treat patients pending regulatory approvals

Psychedelics

Company intends to provide ketamine therapy at a much lower price than a visit to the clinic would cost

Psychedelics

Company will collaborate with Premier Consulting as regulatory partner and utilize Zylö Therapeutics Z-Pod technology

Canada

These relatively new stores remind people about the final days of the cannabis prohibition era in Canada